Skip to main navigation Skip to search Skip to main content

Delivery of TLR7 agonists by Deep-Primed (TM) T cells induces immune activation and improves anti-tumor activity in mice while circumventing systemic toxicity

  • Austin Boesch
  • , Vasily Rybakin
  • , Nathan Westcott
  • , Ji Young Hwang
  • , Kira Røpke Jørgensen
  • , Rasmus Lassen
  • , Martin Kisha Kræmer
  • , Martin Bak
  • , Gael Veiga
  • , Jonas Bruun
  • , Carlos Tassa
  • , Harrison Rodts
  • , Manny Sequeira
  • , Glenn Leary
  • , Santina Caruso
  • , Becker Hewes
  • , Jonathan Fitzgerald
  • , Karsten Sauer
  • , Thomas Lars Andresen
  • Torque Therapeutics

Research output: Contribution to journalConference abstract in journalResearchpeer-review

Original languageEnglish
Article numberP671
JournalJournal for ImmunoTherapy of Cancer
Volume7
Issue numberSuppl. 1
ISSN2051-1426
Publication statusPublished - 2019
Event34th Annual Meeting & Pre-Conference Programs of the Society for Immunotherapy of Cancer (SITC 2019) - Gaylord National Hotel & Convention Center, National Harbour, United States
Duration: 6 Nov 201910 Nov 2019
https://www.sitcancer.org/2019/home

Conference

Conference34th Annual Meeting & Pre-Conference Programs of the Society for Immunotherapy of Cancer (SITC 2019)
LocationGaylord National Hotel & Convention Center
Country/TerritoryUnited States
CityNational Harbour
Period06/11/201910/11/2019
Internet address

Cite this